{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:35:07Z","timestamp":1778888107229,"version":"3.51.4"},"reference-count":9,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0199642","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T13:34:15Z","timestamp":1530884055000},"page":"e0199642","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-266X","authenticated-orcid":true,"given":"Maria Giuseppa","family":"Vitale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Scagliarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Lo Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Defferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Spada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Masini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libero","family":"Ciuffreda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo Maria","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Bengala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Livi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Fagnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Giustini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alketa","family":"Hamzaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Caserta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Sabbatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"ref1","first-page":"433","article-title":"Optimal management of renal cell carcinoma in the elderly: a review","volume":"8","author":"A Quivy","year":"2013","journal-title":"Clin Interv Aging"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.critrevonc.2009.02.005","article-title":"Is age a prognostic factor for treatment outcome in renal cell cancer\u2014A comprehensive review","volume":"72","author":"E Ramos-Barcelo","year":"2009","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jnci\/dji289","article-title":"Annual report to the nation on the status of cancer, 1972\u20132002, featuring population based trends in cancer treatment","volume":"97","author":"BK Edwards","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1517\/14712598.2013.770836","article-title":"Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy","volume":"13","author":"O Hamid","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-065X.2011.01012.x","article-title":"Molecular mechanisms of T-cell tolerance","volume":"241","author":"RI Nurieva","year":"2011","journal-title":"Immunol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"RJ Motzer","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"ref7","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1200\/JCO.2017.35.15_suppl.4577","article-title":"Safety and Efficacy of Nivolumab for Metastatic Renal Cell Carcinoma: Real-World Data From an Italian Expanded Access Program","volume":"35","author":"U De Giorgi","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"ref8","first-page":"CD001425","article-title":"Immunotherapy for advanced renal cell cancer","volume":"25","author":"C Coppin","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1470-2045(16)30107-3","article-title":"Cabozantinib versus Everolimus in advanced renal cell carcinoma (METEOR): final results from a randomized, open-label, phase 3 trial","volume":"17","author":"TK Choueri","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0199642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T08:39:38Z","timestamp":1571560778000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0199642"}},"subtitle":[],"editor":[{"given":"Donald P.","family":"Bottaro","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":9,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0199642","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]}}}